Eph receptors and ephrins in cancer: bidirectional signaling and beyond
(A) EPHA2/HRAS-Erk negative feedback loop. Activation of the HRAS-Erk pathway increases EPHA2 expression through MEK1 and decreases EPHRIN-A1 expression, although it is not known if this also occurs through MEK1,,. In turn, ephrin-dependent EPHA2 activation inhibits HRAS-Erk signaling and also downregulates EPHA2 levels by causing receptor internalization and degradation. (B) Positive and negative EPHB2/MAP kinase feedback loops. In a positive feedback loop, ephrin-B-dependent EPHB2 activation stimulates the HRAS-Erk pathway, and the increase in Mek and/or Erk activity in turn enables enhanced responsiveness of EPHB2 to ephrin-B stimulation through unknown mechanisms. However, in a different cellular context EPHB2 can also inhibit the HRAS-Erk pathway,, which may in turn reduce EPHB2 activation by ephrin. Although not shown in the figure, EPHRIN-B1 stimulation can also downregulate EphB2 levels by causing internalization/degradation. (C) EPHA2/Akt negative feedback loop. The Akt kinase (activated by growth factor receptors (GFR), Src family kinases or mutations in upstream proteins or Akt itself) phosphorylates serine 897 in the carboxy-terminal tail of EPHA2 leading to increased EPHA2-dependent cell migration and invasion. In turn, EPHRIN-A1-induced EPHA2 signaling inactivates Akt by causing its dephosphorylation at T308 and S473, thus decreasing EPHA2 phosphorylation at serine 897 and, consequently, cell migration and invasion. Other pathways downstream of EPHA2 can also inhibit migration and invasion. (D) EPHA2/E-CADHERIN positive feedback loop. E-CADHERIN expression increases EPHA2 expression, surface localization, interaction with EPHRIN-A1, and thus forward signaling, (Box 1). In turn, EPHA2 signaling enhances E-CADHERIN-mediated adhesion. Dotted lines indicate regulation of protein levels rather than activity.